Literature DB >> 10369098

Spatial cognition in males with Fragile-X syndrome: evidence for a neuropsychological phenotype.

K M Cornish1, F Munir, G Cross.   

Abstract

Spatial performance in a group of young Fragile-X syndrome males with FMR-1 full mutation was compared to a learning disabled control group comprising young Down's syndrome males and two control groups of mainstream schoolchildren. Performance was assessed across a wide range of spatial tasks including visuo-construction, visuo-spatial memory, visuo-motor, and visuo-perception. The findings indicate a task-specific rather than global deficit in spatial performance in Fragile-X males with visuo-constructive and visuo-motor skills most vulnerable. Molecular analysis of the lymphocyte DNA found minimal evidence for a correlation between CGG expansion size and spatial performance, although tasks with a visuo-perceptual component correlated negatively with expansion size indicating that the further away the number of repeats are from the 200 threshold the poorer the performance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369098     DOI: 10.1016/s0010-9452(08)70799-8

Source DB:  PubMed          Journal:  Cortex        ISSN: 0010-9452            Impact factor:   4.027


  35 in total

1.  Resolution of spatial and temporal visual attention in infants with fragile X syndrome.

Authors:  Faraz Farzin; Susan M Rivera; David Whitney
Journal:  Brain       Date:  2011-11       Impact factor: 13.501

2.  Selective developmental neuropsychological disorders.

Authors:  Daniel Tranel; Edward de Haan
Journal:  Cortex       Date:  2007-08       Impact factor: 4.027

3.  Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice.

Authors:  Aimee V Franklin; Margaret K King; Valle Palomo; Ana Martinez; Lori L McMahon; Richard S Jope
Journal:  Biol Psychiatry       Date:  2013-09-13       Impact factor: 13.382

4.  Contrast detection in infants with fragile X syndrome.

Authors:  F Farzin; D Whitney; R J Hagerman; S M Rivera
Journal:  Vision Res       Date:  2008-05-23       Impact factor: 1.886

5.  A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome.

Authors:  Laura Greiss Hess; Sarah E Fitzpatrick; Danh V Nguyen; Yanjun Chen; Kimberly N Gaul; Andrea Schneider; Kerrie Lemons Chitwood; Marwa Abd Al Azaim Eldeeb; Jonathan Polussa; David Hessl; Susan Rivera; Randi J Hagerman
Journal:  J Dev Behav Pediatr       Date:  2016-10       Impact factor: 2.225

Review 6.  Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.

Authors:  S M Francis; A Sagar; T Levin-Decanini; W Liu; C S Carter; S Jacob
Journal:  Brain Res       Date:  2014-01-22       Impact factor: 3.252

Review 7.  Autism-lessons from the X chromosome.

Authors:  Elysa J Marco; David H Skuse
Journal:  Soc Cogn Affect Neurosci       Date:  2006-12       Impact factor: 3.436

Review 8.  Fruit flies and intellectual disability.

Authors:  François V Bolduc; Tim Tully
Journal:  Fly (Austin)       Date:  2009-01-12       Impact factor: 2.160

9.  Delineation of early attentional control difficulties in fragile X syndrome: focus on neurocomputational changes.

Authors:  Gaia Scerif; Kim Cornish; John Wilding; Jon Driver; Annette Karmiloff-Smith
Journal:  Neuropsychologia       Date:  2007-01-24       Impact factor: 3.139

10.  Fragile x mental retardation 1 and filamin a interact genetically in Drosophila long-term memory.

Authors:  François V Bolduc; Kimberly Bell; Cory Rosenfelt; Hilary Cox; Tim Tully
Journal:  Front Neural Circuits       Date:  2010-01-08       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.